Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
$67.67
-1.5%
$68.96
$59.83
$87.77
$3.46B1.22381,942 shs455,563 shs
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$189.74
-0.5%
$183.03
$137.99
$198.78
$13.31B0.86412,984 shs356,403 shs
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$2.63
-3.7%
$2.58
$1.05
$3.31
$586.03M0.982.61 million shs2.99 million shs
Zillow Group, Inc. stock logo
ZG
Zillow Group
$77.16
+0.5%
$71.02
$40.30
$86.58
$18.53B2.07502,296 shs459,203 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
-1.57%-3.00%-2.01%+0.25%-8.81%
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
-0.53%-3.20%+3.51%+13.65%+26.30%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-3.66%-0.75%+8.23%+1.94%+19.00%
Zillow Group, Inc. stock logo
ZG
Zillow Group
+0.53%-1.28%+11.91%+14.09%+62.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
2.7929 of 5 stars
2.33.00.00.03.53.31.3
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
4.5603 of 5 stars
1.35.03.32.93.44.21.9
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
2.4132 of 5 stars
4.50.00.00.01.13.30.0
Zillow Group, Inc. stock logo
ZG
Zillow Group
3.5782 of 5 stars
2.23.00.03.41.41.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
2.67
Moderate Buy$80.3318.71% Upside
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
2.60
Moderate Buy$206.408.78% Upside
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
3.00
Buy$8.17210.52% Upside
Zillow Group, Inc. stock logo
ZG
Zillow Group
2.48
Hold$82.456.86% Upside

Current Analyst Ratings Breakdown

Latest HHH, TSHA, ZG, and HLI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/18/2025
Zillow Group, Inc. stock logo
ZG
Zillow Group
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$85.00
7/14/2025
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Moderate Buy$185.00 ➝ $232.00
7/11/2025
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$185.00 ➝ $209.00
7/11/2025
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$8.00
7/8/2025
Zillow Group, Inc. stock logo
ZG
Zillow Group
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$60.00 ➝ $75.00
7/1/2025
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
6/23/2025
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$82.00 ➝ $76.00
6/23/2025
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$159.00 ➝ $192.00
6/10/2025
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
6/3/2025
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$9.00 ➝ $11.00
6/2/2025
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00 ➝ $8.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
$1.75B1.95$9.54 per share7.09$56.65 per share1.19
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$2.39B5.54$6.78 per share27.99$31.20 per share6.08
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$8.33M67.77N/AN/A$0.35 per share7.51
Zillow Group, Inc. stock logo
ZG
Zillow Group
$2.24B8.33$0.72 per share106.96$19.99 per share3.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
$200.55M$5.2112.9973.55N/A14.27%10.21%3.08%N/A
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$399.71M$5.9431.9426.17N/A16.46%23.75%14.21%N/A
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-$89.30M-$0.34N/AN/AN/A-1,201.08%-104.93%-50.09%8/11/2025 (Estimated)
Zillow Group, Inc. stock logo
ZG
Zillow Group
-$112M-$0.34N/A72.1114.18-3.51%-1.62%-1.25%8/6/2025 (Estimated)

Latest HHH, TSHA, ZG, and HLI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2025Q2 2025
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-$0.07N/AN/AN/A$1.61 millionN/A
8/6/2025N/A
Zillow Group, Inc. stock logo
ZG
Zillow Group
$0.44N/AN/AN/A$647.06 millionN/A
7/29/2025Q1 2026
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$1.69$2.14+$0.45$1.42$573.07 million$605.35 million
5/15/2025Q1 2025
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-$0.08-$0.08N/A-$0.08$1.48 million$2.30 million
5/7/2025Q1 2025
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
$0.13$0.21+$0.08$0.21$187.43 million$199.33 million
5/7/2025Q4 2025
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$1.61$1.96+$0.35$1.76$628.25 million$666.42 million
5/7/2025Q1 2025
Zillow Group, Inc. stock logo
ZG
Zillow Group
$0.47$0.41-$0.06$0.03$587.88 million$598.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
N/AN/AN/AN/AN/A
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
$2.401.26%N/A40.40%9 Years
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
N/AN/AN/AN/AN/A
Zillow Group, Inc. stock logo
ZG
Zillow Group
N/AN/AN/AN/AN/A

Latest HHH, TSHA, ZG, and HLI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/29/2025
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
quarterly$0.601.25%9/2/20259/2/20259/15/2025
5/8/2025
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
quarterly$0.601.3%6/2/20256/2/20256/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
1.84
1.41
1.41
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
N/A
1.37
1.14
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
0.77
5.35
5.35
Zillow Group, Inc. stock logo
ZG
Zillow Group
N/A
2.46
2.46

Institutional Ownership

CompanyInstitutional Ownership
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
93.83%
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
78.07%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
77.70%
Zillow Group, Inc. stock logo
ZG
Zillow Group
20.32%

Insider Ownership

CompanyInsider Ownership
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
33.00%
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
23.68%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
3.78%
Zillow Group, Inc. stock logo
ZG
Zillow Group
17.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
Howard Hughes Holdings Inc. stock logo
HHH
Howard Hughes
60850.39 million33.76 millionOptionable
Houlihan Lokey, Inc. stock logo
HLI
Houlihan Lokey
1,10069.79 million53.27 millionOptionable
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
180214.66 million206.55 millionOptionable
Zillow Group, Inc. stock logo
ZG
Zillow Group
6,856241.45 million200.07 millionOptionable

Recent News About These Companies

Zillow sued by CoStar for copyright infringement
ZG Zillow Group, Inc. - Seeking Alpha

New MarketBeat Followers Over Time

Media Sentiment Over Time

Howard Hughes stock logo

Howard Hughes NYSE:HHH

$67.67 -1.06 (-1.54%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$68.57 +0.90 (+1.32%)
As of 08/1/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Howard Hughes Holdings Inc., together with its subsidiaries, operates as a real estate development company in the United States. It operates in four segments: Operating Assets; Master Planned Communities (MPCs); Seaport; and Strategic Developments. The Operating Assets segment consists of developed or acquired retail, office, and multi-family properties along with other retail investments. Its MPCs segment develops, sells, and leases residential and commercial land designated for long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. The Seaport segment is involved in the landlord operations, managed businesses, and events and sponsorships services of its restaurant, retail, and entertain properties in Pier 17, New York City; Historic Area/Uplands; and Tin Building, as well as in 250 Water Street and in the Jean-Georges restaurants. The Strategic Development segment develops and redevelops residential condominiums and commercial properties. It serves homebuilders. Howard Hughes Holdings Inc. was founded in 2010 and is headquartered in The Woodlands, Texas.

Houlihan Lokey stock logo

Houlihan Lokey NYSE:HLI

$189.74 -0.92 (-0.48%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$189.80 +0.05 (+0.03%)
As of 08/1/2025 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, solvency opinions in connection with corporate spin-offs and dividend recapitalizations, and other types of financial opinions. In addition, this segment offers dispute resolution services. It serves corporations, financial sponsors, and government agencies. The company was incorporated in 1972 and is headquartered in Los Angeles, California.

Taysha Gene Therapies stock logo

Taysha Gene Therapies NASDAQ:TSHA

$2.63 -0.10 (-3.66%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.66 +0.03 (+1.14%)
As of 08/1/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.

Zillow Group stock logo

Zillow Group NASDAQ:ZG

$77.16 +0.41 (+0.53%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$77.00 -0.16 (-0.21%)
As of 08/1/2025 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zillow Group, Inc. operates real estate brands in mobile applications and Websites in the United States. The company offers premier agent and rentals marketplaces, new construction marketplaces, advertising, display advertising, and business technology solutions, as well as dotloop and floor plans. It also provides mortgage originations and the sale of mortgages, and advertising to mortgage lenders and other mortgage professionals; and title and escrow services. In addition, the company's brand portfolio includes Zillow Premier Agent, Zillow Home Loans, Zillow Rentals, Trulia, StreetEasy, HotPads, and Out East; and a suite of marketing software and technology solutions for the real estate industry, including ShowingTime+, Spruce, and Follow Up Boss. Zillow Group, Inc. was incorporated in 2004 and is headquartered in Seattle, Washington.